Comparing infection rates of different dialysis catheters
Official title: Comparison of Short-term Application of Dialysis Catheter With Tunnel-cuffed Catheter Versus Non-ccuffed Catheter: a Multicenter Prospective Cohort Study
Run by Beijing Friendship Hospital · NCT06206447 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing whether using tunnel-cuffed catheters or non-cuffed catheters leads to fewer infections in people receiving hemodialysis.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Beijing Friendship Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing) |
| Trial ID | NCT06206447 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who require immediate hemodialysis and have undergone right internal jugular vein catheterization.
✕Probably not a fit
Patients with a history of central venous thrombosis, stenosis, or those on long-term immunosuppression may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, prospective cohort study aims to evaluate the short-term infection rates associated with tunnel-cuffed catheters versus non-cuffed catheters in hemodialysis patients. Participants will be divided into two groups based on the type of catheterization used for right internal jugular vein access. The study will compare the incidence of catheter-related infections, thrombosis, and other complications between these two groups to determine which catheter type is more effective in reducing infection rates.
Why it matters
Potential benefit: If successful, this study could lead to improved catheter selection, reducing infection rates and complications for hemodialysis patients.
How similar studies have gone: Other studies have shown varying results regarding catheter types, making this investigation relevant but not entirely novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ① Age ≥18 years; ② Uremia, clinical evaluation needs to start hemodialysis immediately, and the right internal jugular vein catheterization is the vascular access for the subjects. ③ Subjects who underwent right internal jugular vein catheterization on regular hemodialysis due to poor internal fistula function and the recovery time of internal fistula was ≥4 weeks; ④ Patients with AKI who need renal replacement therapy and underwent catheterization in the right internal jugular vein, and the renal replacement time is ≥4 weeks. Exclusion Criteria: * ① Subjects with previous history of central venous thrombosis, stenosis, infection, etc. ② The subjects were not dialyzed three times a week; ③ Other subjects with central venous catheterization, including left internal jugular vein, femoral vein and subclavian vein; ④ Those who take immunosuppression for a long time.
Where it's running
-
Beijing Friedship Hospital
Beijing, Beijing, China Recruiting
Study contacts
- Study coordinator: Wenhu Liu
- Email: wenhuliu@mail.ccmu.edu.cn
- Phone: 15110124629
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Image-guided platform helps find sentinel lymph nodes in early gastric cancer
This study tests whether an image-guided platform with a deep learning model can find and retrieve sentinel lymph nodes better than standard palpation in people with early gastric cancer undergoing LECS-SNNS.
-
Medical AI fine-tuning platform for major diseases
This study tests a smart AI system that uses hospital data to help diagnose and guide care for patients with chronic gastritis, gastric cancer, reflux, coronary artery disease, or stroke.
-
GERD patient registry study using a large prospective clinical database
A large group of adults with gastroesophageal reflux disease are being looked at in real-world care to see who they are, what treatments they get, and how symptoms and well-being change after treatment.
-
Early Gastric Cancer in China: Real-World Outcomes by Treatment Type
This project will look at real-world outcomes for about 5,000 Chinese patients with early gastric cancer treated with endoscopic resection, laparoscopic surgery, open surgery, or a combined approach to see how treatments relate to survival and recurrence.
-
Nine-grid Zoning Method to guide vertebroplasty for osteoporotic vertebral fractures
This trial tests whether the Nine-grid Zoning Method can make percutaneous vertebroplasty safer and faster for adults with single-segment lumbar osteoporotic vertebral compression fractures.
-
Predicting Colorectal Adenoma Recurrence and Cancer Risk Using Integrated TCM and Western Data
This study tests a risk-prediction model that combines Traditional Chinese Medicine and Western medical features to see if it can forecast recurrence and malignant change in colorectal adenomas.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.